SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-006319
Filing Date
2020-01-23
Accepted
2020-01-23 16:16:22
Documents
1
Period of Report
2020-01-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205717d1_8k.htm 8-K 19615
  Complete submission text file 0001104659-20-006319.txt   20723
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 20542305
SIC: 2836 Biological Products, (No Diagnostic Substances)